You are here: Industry Insights > NDMA

News List

Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US expresspharma
July 27, 2020
Various companies across the globe have announced similar recalls for the product after the USFDA pointed out the presence of NDMA above permissible limits.
Granules Issues Recall of Metformin Hydrochloride Extended-Release Tablets americanpharmaceuticalreview
July 21, 2020
Granules Pharmaceuticals is voluntarily recalling twelve (12) lots of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 and 500 count bottles within expiry to the consumer level due to the detection of NNitrosodimethylamine (NDMA) ...
Several Companies Voluntarily Recall Extended Release Metformin americanpharmaceuticalreview
July 15, 2020
The U.S. Food & Drug Administration (FDA) is alerting patients and health care professionals to several voluntary recalls of extended release (ER) metformin by the companies listed below.
FDA Updates and Press Announcements on NDMA in Metformin fda
July 08, 2020
Today, the AAPS Journal, an official journal of the American Association of Pharmaceutical Scientists, published FDA’s manuscript entitled, “A Cautionary Tale: Quantitative LC-HRMS Analytical Procedures for the Analysis of N-Nitrosodimethylamine in Metfor
Teva Initiates Recall of Metformin Hydrochloride Extended-Release Tablets americanpharmaceuticalreview
June 18, 2020
Teva Pharmaceuticals is voluntarily recalling fourteen (14) lots of Metformin Hydrochloride Extended-Release Tablets, USP 500 mg and 750 mg, 100 and 1000 count bottles ...
Lupin voluntarily recalls a lot of diabetes drug in the US expresspharma
June 16, 2020
An FDA analysis showed that this lot exceeded the acceptable daily intake limit for NDMA, an impurity that can cause cancer.
Marksans Pharma recalls 11,279 bottles of diabetes drug due to cancer causing chemical expresspharma
June 11, 2020
The company has issued voluntary recall of one batch of Metformin extended release tablets (USP 500 mg) due to detection of NDMA.
Marksons Pharma voluntarily recalls a batch of Metformin XR tablets expresspharma
June 09, 2020
Marksans Pharma has issued a voluntary recall of one batch of Metformin Extended-Release Tablets USP 500 mg (11279 bottles, Lot No. XP9004), informed the company through a statement.
Amneal recalls Metformin Hydrochloride Extended Release Tablets to consumer level europeanpharmaceuticalreview
June 08, 2020
The voluntary recall of Metformin Hydrochloride Extended Release Tablets, 500 mg and 750 mg is due to unacceptable levels of NDMA impurities.
Apotex Issues Recall of Metformin Hydrochloride Extended-Release Tablets 500mg americanpharmaceuticalreview
June 05, 2020
Apotex is voluntarily recalling all lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg within expiry to retail level.

Previous page 1 2 3 4 Next page